CDSCO Panel Approves Eli Lilly's Protocol Amendment Proposal for Retatrutide study Dr. Divya Colin19 Jan 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves Eli Lilly's Protocol Amendment proposal to study Anti-cancer Drug LY3537982 Dr. Divya Colin10 Jan 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves Novartis Protocol Amendment Proposal for Ruxolitinib study Dr. Divya Colin4 Jan 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves Eli Lilly's Protocol Amendment Proposal for Antidiabetic Drug Retatrutide study Dr. Divya Colin29 Dec 2024 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Eli...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal To Study antihypertensive drug Baxdrostat Dr. Divya Colin29 Dec 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the pharmaceutical...
CDSCO Panel Approves GSK Protocol Amendment proposal for Belrestotug and Dostarlimab study Dr. Divya Colin27 Dec 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
CDSCO Panel Approves Novartis Protocol Amendment Proposal for Ianalumab Study Dr. Divya Colin23 Dec 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal For Anti-cancer Drug Volrustomig study Dr. Divya Colin22 Dec 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved AstraZeneca's...
CDSCO Panel Approves Novartis's Protocol Amendment Proposal to Study Ianalumab Dr. Divya Colin1 Nov 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO panel approves Sanofi Healthcare's protocol amendment proposal to study SAR441566 Dr. Divya Colin1 Nov 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
CDSCO Panel grants Novo Nordisk Protocol Amendment Proposal to study concizumab Dr. Divya Colin27 Oct 2024 5:00 PM ISTNew Delhi: Recommending to increase the number of subjects from 15 to 35, the Subject Expert Committee (SEC) functional under the Central Drug...
CDSCO Panel Approves IQVIA RDS Protocol Amendment Proposal for Survodutide study Dr. Divya Colin2 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
